Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic MEN1 gene mutation in MEN2A-associated hyperplasia
- 30 June 2000
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 54, 100s-103s
- https://doi.org/10.1016/s0753-3322(00)80023-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Alterations of the MEN1 Gene in Sporadic Parathyroid TumorsJournal of Clinical Endocrinology & Metabolism, 1998
- Parathyroid MEN1 Gene Mutations in Relation to Clinical Characteristics of Nonfamilial Primary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1998
- Germline Dinucleotide Mutation in Codon 883 of the RETProto-Oncogene in Multiple Endocrine Neoplasia Type 2B Without Codon 918 MutationJournal of Clinical Endocrinology & Metabolism, 1997
- Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1Science, 1997
- Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?Journal of Clinical Endocrinology & Metabolism, 1996
- Loss of The Retinoblastoma Tumor-Suppressor Gene in Parathyroid CarcinomaNew England Journal of Medicine, 1994
- Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumoursHuman Molecular Genetics, 1994
- Absence of p53 point mutations in parathyroid adenoma and carcinomaJournal of Clinical Endocrinology & Metabolism, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Clonality of Parathyroid Tumors in Familial Multiple Endocrine Neoplasia Type 1New England Journal of Medicine, 1989